top of page
Cluster News
Understanding innovative purchasing in hospitals with the RESAH
Understanding innovative purchasing in hospitals with the RESAH
Mar 27
Heading international with Business France: relive our webinar dedicated to the internationalization of innovations in oncology
On September 9, the Paris Saclay Cancer Cluster (PSCC) organized an exclusive webinar in partnership with Business France , dedicated to opportunities and support systems for the international development of innovative health companies . This meeting provided project leaders and start-ups in the sector with information on the key steps for a successful establishment abroad and on the tools made available by Business France to support their expansion. On the program: Prese
Oct 15, 2025
Webinar - Discover CellAction, the cell and gene therapy platform
The replay of the webinar " Discover CellAction, the cell and gene therapy platform " from June 25, 2025 is already available! Discover...
Jun 26, 2025
Webinar - Moving to Campus Grand Parc: Everything you need to know! Replay available
The replay of the webinar on Campus Grand Parc from May 22 is already available! Are you working on an oncology project? Biotech,...
May 22, 2025
Webinar Replay - Discover the services offered by the PSCC Support and Orientation Office
The PSCC gives innovators (project leaders, start-ups, entrepreneurs and industrialists) access to the best experts in the field,...
Apr 7, 2025
Replay: Webinar - Presentation of SIDIV
On December 19 , the PSCC organized a Webinar presenting SIDIV, the privileged contact and reference for public authorities for in...
Dec 20, 2024
Replay: Webinar - Collaborating with Patients to Move Your Projects Forward
On December 10 at 1 p.m. , the PSCC hosted a Patient Webinar to educate the innovation community on how to integrate patients into...
Dec 12, 2024
Replay: Presentation of Snitem to the PSCC community
On November 28 at 2 p.m. , the PSCC had the pleasure of welcoming Snitem , a privileged contact and public authority representative for...
Nov 28, 2024
Cluster News
In Villejuif, the Paris-Saclay Cancer Cluster deploys an operational model to accelerate innovation in oncology
Villejuif, February 4, 2026 - On World Cancer Day , the Paris-Saclay Cancer Cluster (PSCC) is hosting the 3rd edition of its PSCC Innovation Forum in Villejuif. More than 700 oncology stakeholders -researchers, clinicians, start-ups, industrial players, investors, and patient representatives - are gathering around a shared conviction: t he future of oncology now lies in the ability to rapidly translate scientific innovation into tangible clinical impact. Each year, nearly 4
Feb 4
(In French) Hack4Hope 2025 : Ensemble pour transformer la prise en charge des cancers pédiatriques
Une deuxième édition ambitieuse dédiée aux cancers de l’enfant et de l’adolescent , organisée par le PSCC et son Childhood Cancer Working Group, avec le soutien de LifeArc, Foundation S, Imagine for Margo, Sanofi et Bristol Myers Squibb. 9 projets finalistes sélectionnés parmi 24 candidatures, couvrant thérapies innovantes, IA, diagnostics, nanomédecine et soutien aux familles. 4 gagnants distingués par le jury : Kindling Bio (1er Prix), MSInsight (2e Prix), Hippoxis (3e Pr
Dec 5, 2025
(In French) À The Hive, le Central Lab et l’Innovation Center dévoilent leur offre aux sociétés innovantes en oncologie du PSCC
Premier événement scientifique organisé au sein de The Hive , bâtiment totem du biocluster, au cœur du Campus Grand Parc Lancement du Central Lab , bientôt opérationnel pour accompagner les projets précliniques et cliniques Déploiement de l’ Innovation Center , une offre modulable destinée aux jeunes start-ups Présentation de deux nouveaux locataires de The Hive : Valerio Therapeutics , et Signadori Bio Villejuif, le 04 décembre 2025 – Organisée à The Hive, bâtiment de 25
Dec 4, 2025
(in french) Déploiement du système robotique ION : La biopsie robot-assistée qui révolutionne le traitement et le diagnostic du cancer du poumon est en place à l’Hôpital Marie-Lannelongue
Paris, France, 11 septembre, 2025 — L’Hôpital Marie-Lannelongue, le Centre International des Cancers Thoraciques (CICT) et le Paris...
Sep 12, 2025
Cluster News
Standardize and scale tumor organoids to accelerate innovation in oncology.
On April 7, 2026, the Ecosystem Breakfast took place on the theme " Standardize and scale tumor organoids to accelerate innovation in oncology"; the replay is now available. With : Benjamin Saulnier: CEO of Cellura (SoftCell Therapeutics) . Access the replay
5 days ago
Understanding innovative purchasing in hospitals with the RESAH
Understanding innovative purchasing in hospitals with the RESAH
Mar 27
New start-ups join the PSCC BOOST programme
Five innovative oncology-focused projects have been selected through the BOOST programme and join the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From cell therapies to gene delivery, theranostics, vaccines and advanced imaging technologies , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of scientific breakthroughs into tangible impact for p
Mar 25
InnPROGRESS platform: Gustave Roussy's expertise in clinical trial design
On March 10, 2026, the Ecosystem Breakfast was held on the theme “InnPROGRESS platform: Gustave Roussy's expertise in clinical trial design.” The replay is now available. With: Prof. Benjamin Besse: Professor Benjamin Besse is Director of Clinical Research at Gustave Roussy and Professor of Medical Oncology at Paris-Saclay University. As a medical oncologist, his research focuses on the application of personalized therapeutic strategies based on molecular abnormalities, circ
Mar 11
Cluster News
New start-ups join the PSCC BOOST programme
Five innovative oncology-focused projects have been selected through the BOOST programme and join the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From cell therapies to gene delivery, theranostics, vaccines and advanced imaging technologies , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of scientific breakthroughs into tangible impact for p
Mar 25
New start-ups join the PSCC BOOST programme
For the beginning of 2026, five innovative oncology-focused projects were successful in the selection process and join the BOOST programme of the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From novel therapeutic modalities to next-generation biologics , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of breakthrough science into tangible imp
Jan 7
9 new projects supported by the PSCC
From diagnosis to therapies, from molecules to algorithms: innovation takes multiple forms within the Paris Saclay Cancer Cluster (PSCC)....
Sep 25, 2025
8 new projects to be supported by the PSCC
We are thrilled to announce that 5 new projects have been selected by the PSCC to benefit from its support: Carla Biotherapeutics : A...
Jun 23, 2025
Cluster News
Les Echos - A Villejuif, le cluster de l'oncologie prend de l'ampleur (in french)
Huit entreprises, 250 salariés et un fonds de subvention de 2,5 millions d'euros… Le Paris-Saclay Cancer Cluster met les bouchées doubles à Villejuif pour accélérer le passage de la recherche à la fabrication de traitement contre le cancer. Le Paris-Saclay Cancer Cluster met les bouchées doubles. Ce cluster, financé par l'Etat à hauteur de 100 millions d'euros, développe un pôle consacré à l'oncologie et à la déclinaison de la recherche en traitement pour trouver des solution
Feb 6
Mind Health - Le PSCC dévoile ses ambitions pour 2026 (in French)
Le Paris-Saclay Cancer Cluster (PSCC), le biocluster dédié à l'oncologie, a présenté le 4 février un bilan de son activité depuis sa création en 2022 à l'occasion du PSCC Innovation Forum 2026. Son Campus, doté d'un investissement de 1,8 Mds €, sort progressivement de terre : 45 000 m² de laboratoires et de bureaux sont opérationnels depuis 2025. En janvier, sept entreprises, dont Sanofi et One Biosciences, ont déjà rejoint le cluster et le PSCC vise l'installation de plus de
Feb 6
L'Express - Visite exclusive au cœur du "Paris-Saclay Cancer Cluster" : "Grâce à cet incubateur, tout va plus vite (in french)
Reportage. Sous l’impulsion d’Emmanuel Macron, la France tente d’ériger à Villejuif un incubateur géant pour aider les scientifiques à transformer leurs idées en médicaments. C'est vrai que l'on s’y perd dans ces couloirs où rien n’est indiqué, au milieu de toutes ces salles nues, qui attendent encore qu’on les habille de meubles et de moquettes. Le "Paris-Saclay Cancer Cluster", projet d’incubateur inédit en France, n’est pas tout à fait fini, et cela se devine à tous ces sa
Feb 3
L'Express - Cancer, les vrais progrès de la science : "La frontière de la guérison a bougé"
Sciences et santé. Les médecins arrivent désormais à prolonger la vie de certains patients atteints de tumeurs métastatiques. Une révolution, même si le cancer reste la première cause de décès dans notre pays. On dit de Valérie, 56 ans, qu’elle a "bonne mine". Qu’elle n’a pas l’air "malade". Peut-être est-ce dû à cet infatigable entrain, elle qui a toujours eu une énergie "débordante" et mille projets à la fois, cadre dans l’assurance et élue d’une petite commune du sud de la
Nov 26, 2025
Cluster News
Standardize and scale tumor organoids to accelerate innovation in oncology.
On April 7, 2026, the Ecosystem Breakfast took place on the theme " Standardize and scale tumor organoids to accelerate innovation in oncology"; the replay is now available. With : Benjamin Saulnier: CEO of Cellura (SoftCell Therapeutics) . Access the replay
5 days ago
Understanding innovative purchasing in hospitals with the RESAH
Understanding innovative purchasing in hospitals with the RESAH
Mar 27
New start-ups join the PSCC BOOST programme
Five innovative oncology-focused projects have been selected through the BOOST programme and join the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From cell therapies to gene delivery, theranostics, vaccines and advanced imaging technologies , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of scientific breakthroughs into tangible impact for p
Mar 25
InnPROGRESS platform: Gustave Roussy's expertise in clinical trial design
On March 10, 2026, the Ecosystem Breakfast was held on the theme “InnPROGRESS platform: Gustave Roussy's expertise in clinical trial design.” The replay is now available. With: Prof. Benjamin Besse: Professor Benjamin Besse is Director of Clinical Research at Gustave Roussy and Professor of Medical Oncology at Paris-Saclay University. As a medical oncologist, his research focuses on the application of personalized therapeutic strategies based on molecular abnormalities, circ
Mar 11
bottom of page